Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma

American Journal of Surgery

Volumn 192, Issue 6, 2006, Pages 878-881

  Pearlman, Nathan W ^a   McCarter, Martin D ^a   Frank, Matthew ^b   Hurtubis, Cheryl ^b   Merkow, Ryan P ^a   Franklin, Wilbur A ^b   Gonzalez, Rene ^b   Lewis, Karl ^b   Roaten, J Brent ^a   Robinson, William A ^b  

^a UNIVERSITY OF COLORADO HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Melanoma; Prognosis; Sentinel lymph node metastatic size

Indexed keywords

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INCIDENCE; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 33845289452     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2006.08.062     Document Type: Article

References (14)

1. Wagner J.D., Gordon M.S., Chuang T.-Y., et al. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer 89 (2000) 453-462
2. McMasters K.M., Wong S.L., Edwards M.J., et al. Frequency of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 9 (2002) 137-141
3. Carlson G.W., Murray D.R., Lyles R.H., et al. The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance?. Ann Surg Oncol 10 (2003) 575-581
4. Reeves M.E., Delgado R., Busam K.J., et al. Prediction of nonsentinel lymph node status in melanoma. Ann Surg Oncol 20 (2003) 27-31
5. Lee J.H., Essner R., Hitoe T.-I., et al. Factors predictive of tumor-positive non-sentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma. Clin Oncol 22 (2004) 3677-3684
6. Dewar D.J., Newell B., Green M.A., et al. The microanatomic location of meta-static melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 16 (2004) 3345-3349
7. Starz H., Siedlecki K., and Balda B.-R. Sentinel lymphonodectomy and S-classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol 11 (2004) 162S-8
8. Sabel M.S., Griffith K., Sondak V.K., et al. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg 201 (2005) 37-47
9. th ed. (2002), Springer-Verlag, New York
10. Spanknebel K., Coit D.G., Bieligk S.C., et al. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol 29 (2005) 305-317
11. Cook M.G., Green M.A., Anderson B., et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 200 (2003) 314-319
12. Lewis K.D., Robinson W.A., McCarter M.D., et al. Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma. J Clin Oncol 24 (2006) 3157-3163
13. Ranieri J.M., Wagner J.D., Azuaje R., et al. Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy. Ann Surg Oncol 9 (2002) 975-981
14. Scoggins C.R., Ross M.I., Reintgen D.S., et al. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol 24 (2006) 2849-2857